Product Information
CYPROHEPTADINE 4 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0679 per EA under NDC 64380079508. Its NADAC has been published 422 times since Sep 5, 2018.
FDA first approved this application on Apr 11, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
4 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380079508
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209172FDA Approved
4/11/2018
TE Code
AA
On Market Since
4/11/2018
Price Statistics
The NADAC for CYPROHEPTADINE 4 MG TABLET has been published 422 times since Sep 5, 2018, and over the history we have for it it has declined 71.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0679 per EA |
|---|---|
| All-time high | $0.2487 (Oct 10, 2018) |
| All-time low | $0.0644 (Apr 22, 2026) |
| 52-week high | $0.0775 |
| 52-week low | $0.0644 |
| Median price | $0.0945 |
| Average price | $0.1175 |
| Largest weekly change | -25.5% (Jun 23, 2021) |
| Weeks tracked | 422 |
| Tracking since | Sep 5, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CYPROHEPTADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 4 MG TABLET, manufactured by Strides Pharma Inc., is $0.0679 per EA (NDC 64380079508), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 4 MG TABLET has declined 71.9%. It has been tracked across 422 weekly CMS publications since Sep 5, 2018.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 4 MG TABLET?
Since Sep 5, 2018, the NADAC for CYPROHEPTADINE 4 MG TABLET has ranged from a low of $0.0644 (Apr 22, 2026) to a high of $0.2487 (Oct 10, 2018), with a median of $0.0945 per EA.
Are there cheaper alternatives to CYPROHEPTADINE 4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYPROHEPTADINE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYPROHEPTADINE 4 MG TABLET?
CYPROHEPTADINE 4 MG TABLET (NDC 64380079508) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.